Conference abstractPublished 2 Jul 2012
From immunochemistry to multispectral imaging of tissue biomarkers
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Despite the growing demand for true quantitative biomarker (BM) assays, many pathologists are not yet convinced that there is a need for any tools beyond their eyes. We are interested in developing analytic tools and algorithms to discover in tissue proteins that are of the potential utility as diagnostic and prognostic BMs or therapeutic targets. Specifically, we aim to identify protein BMs that determine the likelihood that precancerous lesions remain contained in situ, as opposed to becoming invasive. Although a variety of quantitative methods exist for assaying biofluid-based BMs, contemporary proteomic technologies remain impractical for application to archived clinical samples that provide a trove of information for BM discovery. We developed monochrome imaging-based method � without use of sophisticated and expensive equipment � to measure protein expression in formalin-fixed paraffin-embedded (FFPE) tissue. The measurements are performed on a continuous biologically relevant scale and the quantification of relative (rather then absolute) intensity of staining takes into account fluctuations of background staining. Using this approach, we found that increased expression of the insulin-like growth factor type I receptor (IGF-IR) and its target, Ras-related protein 1 (Rap1) was associated with risk of progression in patients diagnosed with breast carcinoma in situ. To streamline development of novel tissue BMs, we have been taking advantage of multispectral imaging (MSI) technology. MSI, previously successfully applied to space and military applications, now offers promise of both extending the power and value of tissue examination. The pros and cons of imaging technologies enabling BM identification in tissue will be presented.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Biomarkers & Diagnosis
- SubjectGenetics & Molecular Biology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Marina Guvakova”
